Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species

Details for Australian Patent Application No. 2009215129 (hide)

Owner Hemispherx Biopharma, Inc.

Inventors Strayer, David; Carter, William A.

Agent Cullens

Pub. Number AU-A-2009215129

PCT Pub. Number WO2009/102497

Priority 61/051,366 08.05.08 US; 61/029,308 15.02.08 US

Filing date 17 February 2009

Wipo publication date 20 August 2009

International Classifications

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 31/19 (2006.01)

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/02 (2006.01) Antiparasitic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

9 September 2010 PCT application entered the National Phase

  PCT publication WO2009/102497 Priority application(s): WO2009/102497

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009215144-Aircraft flight plan optimization for minimizing emissions

2009215128-Selective agonist of toll-like receptor 3